Anne O’Dea

Randomized Phase II Trial of Endocrine Therapy With or Without Ribociclib After Progression on Cyclin-Dependent Kinase 4/6 Inhibition in Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer: MAINTAIN Trial

Kevin Kalinsky, Melissa Accordino, Codruța Chiuzan et al. · Journal of Clinical Oncology · 2023 · 191 citations

Medicine, Oncology, Pharmacology +17

Effect of vitamin D supplementation on serum 25-hydroxy vitamin D levels, joint pain, and fatigue in women starting adjuvant letrozole treatment for breast cancer

Qamar J. Khan, Pavan S. Reddy, Bruce F. Kimler et al. · Breast Cancer Research and Treatment · 2009 · 186 citations

Medicine, Oncology, Breast Oncology +14

Clinical and Biomarker Findings of Neoadjuvant Pembrolizumab and Carboplatin Plus Docetaxel in Triple-Negative Breast Cancer

Priyanka Sharma, Shane R. Stecklein, Rachel Yoder et al. · JAMA Oncology · 2023 · 164 citations · Full text

Medicine, Oncology, Pharmacology +17

Pathological Response and Survival in Triple-Negative Breast Cancer Following Neoadjuvant Carboplatin plus Docetaxel

Priyanka Sharma, Sara López‐Tarruella, José Á. García-Sáenz et al. · Clinical Cancer Research · 2018 · 128 citations · Full text

Medicine, Oncology, Pharmacology +17

Randomized Phase II Trial of Anthracycline-free and Anthracycline-containing Neoadjuvant Carboplatin Chemotherapy Regimens in Stage I–III Triple-negative Breast Cancer (NeoSTOP)

Priyanka Sharma, Bruce F. Kimler, Anne O’Dea et al. · Clinical Cancer Research · 2020 · 109 citations · Full text

Medicine, Oncology, Pharmacology +17